Name File Type Size Last Modified
  Dunn_cholesterol 10/12/2019 04:03:PM
LICENSE.txt text/plain 14.6 KB 10/12/2019 12:03:PM

Project Citation: 

Dunn, Abe. Replication data for: Drug Innovations and Welfare Measures Computed from Market Demand: The Case of Anti-cholesterol Drugs. Nashville, TN: American Economic Association [publisher], 2012. Ann Arbor, MI: Inter-university Consortium for Political and Social Research [distributor], 2019-10-12. https://doi.org/10.3886/E113824V1

Project Description

Summary:  View help for Summary The pharmaceutical industry is characterized as having substantial investment in R&D and a large number of new product introductions, which poses special problems for price measurement caused by the quality of drug products changing over time. This paper applies recent demand estimation techniques to individual-level data to construct a constant-quality price index for anti-cholesterol drugs. Although the average price for anti-cholesterol drugs does not change over the sample period, I find that the constant-quality price index drops by 27 percent, a pace more in line with our expectations in such a dynamic segment of the industry. (JEL C43, L11, L65, O31)

Scope of Project

JEL Classification:  View help for JEL Classification
      C43 Index Numbers and Aggregation; Leading indicators
      L11 Production, Pricing, and Market Structure; Size Distribution of Firms
      L65 Chemicals; Rubber; Drugs; Biotechnology; Plastics
      O31 Innovation and Invention: Processes and Incentives


Related Publications

Published Versions

Export Metadata

Report a Problem

Found a serious problem with the data, such as disclosure risk or copyrighted content? Let us know.

This material is distributed exactly as it arrived from the data depositor. ICPSR has not checked or processed this material. Users should consult the investigator(s) if further information is desired.